Despite past failures, Denali's extensive pipeline and solid financial runway make it a compelling buy at current low stock ...
Two years previously, TKT signed an exclusive licensing agreement with Genzyme Corporation to market Elaprase (idursulfase), which is a drug used to treat Hunter syndrome (also called MPS-II), in ...